Publikationen, an denen er mitarbeitet Rafael Jiménez Fernández (19)

2010

  1. Effect of an antioxidant functional food beverage on exercise-induced oxidative stress: A long-term and large-scale clinical intervention study

    Toxicology, Vol. 278, Núm. 1, pp. 101-111

2009

  1. The role of cellular plasticity in cancer development

    Current Medicinal Chemistry, Vol. 16, Núm. 28, pp. 3676-3685

2008

  1. Antioxidantes, atividade física e estresse oxidativo em mulheres idosas

    Revista Brasileira de Medicina do Esporte, Vol. 14, Núm. 1, pp. 8-11

2006

  1. Exercise, oxidative stress and risk of cardiovascular disease in the elderly. Protective role of antioxidant functional foods

    BioFactors, Vol. 27, Núm. 1-4, pp. 167-183

2004

  1. Effects of S-adenosylmethionine on intrabiliary glutathione degradation induced by long-term administration of cyclosporin A in the rat

    Toxicology, Vol. 200, Núm. 1, pp. 21-27

  2. S-Adenosylmethionine protects against intrabiliary glutathione degradation induced by long-term administration of cyclosporin A in the rat

    Toxicology, Vol. 201, Núm. 1-3, pp. 239-245

2003

  1. Effects of aging and cyclosporin treatment on the hepatobiliary efflux of glutathione

    Life Sciences, Vol. 73, Núm. 26, pp. 3387-3397

2001

  1. Effects of aging on the susceptibility to the toxic effects of cyclosporin A in rats. Changes in liver glutathione and antioxidant enzymes

    Free Radical Biology and Medicine, Vol. 30, Núm. 8, pp. 836-845

2000

  1. Glutathione metabolism in cyclosporine A-treated rats: Dose- and time-related changes in liver and kidney

    Clinical and Experimental Pharmacology and Physiology, Vol. 27, Núm. 12, pp. 991-996

  2. Role of S-adenosylmethionine on the hepatobiliary homeostasis of glutathione during cyclosporine A treatment

    Journal of Physiology and Biochemistry, Vol. 56, Núm. 3, pp. 189-199

1999

  1. S-adenosylmethionine protects against cyclosporin A-induced alterations in rat liver plasma membrane fluidity and functions

    Journal of Pharmacology and Experimental Therapeutics, Vol. 290, Núm. 2, pp. 774-781

1998

  1. Inhibition of biliary glutathione secretion by cyclosporine A in the rat: Possible mechanisms and role in the cholestasis induced by the drug

    Journal of Hepatology, Vol. 29, Núm. 1, pp. 68-77

1996

  1. Acid-base disturbances in the rabbit during experimental hepatic parasitosis

    Parasitology Research, Vol. 82, Núm. 6, pp. 524-528

1995

  1. CYCLOSPORINE A HEPATOTOXICITY: EFFECT OF PROLONGED TREATMENT WITH CYCLOSPORINE ON BILIARY LIPID SECRETION IN THE RAT

    Clinical and Experimental Pharmacology and Physiology, Vol. 22, Núm. 4, pp. 260-265

  2. Reversal of cyclosporine A-induced alterations in biliary secretion by S- adenosyl-L-methionine in rats

    Journal of Pharmacology and Experimental Therapeutics, Vol. 275, Núm. 1, pp. 442-449

1992

  1. Conceptos básicos de la Fisiología Hepatobiliar

    Temas actuales de nutrición artificial (Enrique Martínez Fidalgo), pp. 59-84

  2. Cyclosporin A-Induced Cholestasis in the Rat: Beneficial Effects of S-Adenosyl-L-Methionine

    Drug Investigation, Vol. 4, Núm. 4, pp. 54-63

1991

  1. Impairment of maximal bilirubin secretion by cyclosporin A in the rat.

    Archives internationales de physiologie, de biochimie et de biophysique, Vol. 99, Núm. 6, pp. 373-376

1990

  1. Effects of ursodeoxycholate on maximal biliary secretion of bilirubin in the rat

    Biochemical Pharmacology, Vol. 39, Núm. 7, pp. 1175-1180